Virpax Pharmaceuticals (VRPX) Short Interest Ratio & Short Volume $0.01 0.00 (0.00%) As of 08/29/2025 Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Virpax Pharmaceuticals Short Interest DataVirpax Pharmaceuticals (VRPX) has a short interest of 11,900 shares, representing 0.25% of the float (the number of shares available for trading by the public). This marks a -22.73% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 166,969 shares to cover all short positions.Current Short Interest11,900 sharesPrevious Short Interest15,400 sharesChange Vs. Previous Month-22.73%Dollar Volume Sold Short$130.90Short Interest Ratio0.5 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares1,242,000 sharesShort Percent of Float0.25%Today's Trading Volume0 sharesAverage Trading Volume166,969 sharesToday's Volume Vs. Average0% Short Selling Virpax Pharmaceuticals? Sign up to receive the latest short interest report for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVRPX Short Interest Over TimeVRPX Days to Cover Over TimeVRPX Percentage of Float Shorted Over Time Virpax Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/202511,900 shares $130.90 -22.7%0.3%0.5 $0.01 7/15/202515,400 shares $5.56 thousand -58.5%N/A0.6 $0.36 6/30/202537,100 shares $11.72 thousand +18.2%0.8%1.2 $0.32 6/15/202531,400 shares $7.29 thousand +119.6%0.7%1.3 $0.23 5/31/202514,300 shares $3.51 thousand -3.4%0.3%0.6 $0.25 5/15/202514,800 shares $3.58 thousand +0.7%N/A0.8 $0.24 4/30/202514,700 shares $3.90 thousand -48.4%N/A0.5 $0.27 4/15/202528,500 shares $6.56 thousand -91.1%N/A0.1 $0.23 3/31/2025319,800 shares $383.76 thousand +1,284.4%26.2%0.8 $1.20 3/15/202523,100 shares $96.15 thousand -97.6%1.9%0.1 $4.16 Get the Latest News and Ratings for VRPX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/28/2025955,300 shares $229.27 thousand -39.2%3.7%0.2 $0.24 2/15/20251,570,000 shares $512.29 thousand +148.7%8.7%0.2 $0.33 1/31/2025631,300 shares $197.03 thousand +437.3%3.6%0.2 $0.31 1/15/2025117,500 shares $41.13 thousand -74.3%0.8%0 $0.35 12/31/2024457,500 shares $173.80 thousand +90.3%3.2%0.1 $0.38 12/15/2024240,400 shares $96.16 thousand -37.8%3.1%0.1 $0.40 11/30/2024386,500 shares $178.18 thousand +22.7%5.1%0.1 $0.46 11/15/2024315,000 shares $193.47 thousand -10.2%4.2%0.1 $0.61 10/31/2024350,900 shares $257.21 thousand -38.0%7.6%1.2 $0.73 10/15/2024565,500 shares $249.95 thousand +46.7%12.3%1.5 $0.44 9/30/2024385,600 shares $267.76 thousand -7.2%8.4%0.1 $0.69 9/15/2024415,300 shares $344.03 thousand -20.6%9.1%0.1 $0.83 8/31/2024523,200 shares $426.51 thousand +241.1%11.4%0.1 $0.82 8/15/2024153,400 shares $130.24 thousand -42.9%3.3%0 $0.85 7/31/2024268,400 shares $327.45 thousand -57.5%6.2%0 $1.22 7/15/2024631,600 shares $675.81 thousand +1,625.7%14.8%0.1 $1.07 6/30/202436,600 shares $18.93 thousand +28.4%1.5%0 $0.52 6/15/202428,500 shares $19.53 thousand -49.7%1.2%0.2 $0.69 5/31/202456,700 shares $39.69 thousand -28.8%2.8%0.6 $0.70 5/15/202479,600 shares $62.09 thousand +907.6%5.1%0.9 $0.78 4/30/20247,900 shares $21.41 thousand -46.6%0.9%0.3 $2.71 4/15/202414,800 shares $52.25 thousand -50.3%1.7%0.6 $3.53 3/31/202429,800 shares $126.98 thousand +24.7%3.4%1.3 $4.26 3/15/202423,900 shares $99.66 thousand +119.3%2.8%1 $4.17 2/29/202410,900 shares $33.27 thousand -82.5%1.3%0.3 $3.05 2/15/202462,400 shares $22.94 thousand -12.2%0.7%0.2 $0.37 1/31/202471,100 shares $23.39 thousand +38.1%0.8%0.2 $0.33 1/15/202451,500 shares $13.75 thousand -44.1%0.6%0.2 $0.27 12/31/202392,100 shares $29.48 thousand +479.3%1.1%0.3 $0.32 12/15/202315,900 shares $6.22 thousand -58.4%0.2%0.1 $0.39Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why (Ad)Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.Click here for the full story. 11/30/202338,200 shares $15.27 thousand -30.3%0.4%0.7 $0.40 11/15/202354,800 shares $40.66 thousand -8.8%0.6%2.1 $0.74 10/31/202360,100 shares $42.98 thousand +110.1%0.7%2.4 $0.72 10/15/202328,600 shares $23.46 thousand -40.3%0.3%1.1 $0.82 9/30/202347,900 shares $38.32 thousand +197.5%0.6%2.3 $0.80 9/15/202316,100 shares $12.70 thousand -37.6%0.2%0.7 $0.79 8/31/202325,800 shares $22.19 thousand -22.8%0.3%0.8 $0.86 8/15/202333,400 shares $29.89 thousand -20.1%0.4%1 $0.90 7/31/202341,800 shares $37.20 thousand +1.7%0.5%1.3 $0.89 7/15/202341,100 shares $40.28 thousand -48.1%0.5%1.3 $0.98 6/30/202379,200 shares $85.54 thousand +56.8%0.9%2.6 $1.08 6/15/202350,500 shares $46.46 thousand -35.2%0.6%1.8 $0.92 5/31/202377,900 shares $61.14 thousand -26.1%0.9%4.2 $0.78 5/15/2023105,400 shares $90.65 thousand +22.3%1.2%6.1 $0.86 4/30/202386,200 shares $61.25 thousand +2.9%1.0%4.1 $0.71 4/15/202383,800 shares $64.29 thousand -7.7%1.0%2.1 $0.77 3/31/202390,800 shares $71.28 thousand +7.3%1.0%2.3 $0.79 3/15/202384,600 shares $67.68 thousand +6.8%1.0%1.8 $0.80 2/28/202379,200 shares $74.68 thousand -40.4%0.9%1.6 $0.94 2/15/2023132,900 shares $145.34 thousand +285.2%1.6%2.6 $1.09 1/31/202334,500 shares $34.15 thousand +1.8%0.4%0.7 $0.99 1/15/202333,900 shares $28.14 thousand -18.9%0.4%0.9 $0.83 12/30/202241,800 shares $26.01 thousand -51.1%0.5%1 $0.62 12/15/202285,400 shares $68.32 thousand +100.9%1.0%2.3 $0.80 11/30/202242,500 shares $35.70 thousand +21.1%0.5%1.2 $0.84 11/15/202235,100 shares $30.11 thousand +19.0%0.4%1 $0.86 10/31/202229,500 shares $31.57 thousand +16.6%0.3%0.7 $1.07 10/15/202225,300 shares $27.07 thousand -39.3%0.3%0.5 $1.07 9/30/202241,700 shares $49.62 thousand +37.6%0.5%0.9 $1.19 9/15/202230,300 shares $39.69 thousand +5.6%0.4%0.6 $1.31 8/31/202228,700 shares $36.45 thousand -22.9%0.3%0.5 $1.27 8/15/202237,200 shares $62.50 thousand -45.7%0.4%0.6 $1.68 7/31/202268,500 shares $104.12 thousand +78.9%0.8%0.8 $1.52 7/15/202238,300 shares $62.05 thousand -41.1%0.5%0.3 $1.62 6/30/202265,000 shares $109.20 thousand -15.1%0.8%0.4 $1.68 6/15/202276,600 shares $107.24 thousand -12.6%0.9%0.5 $1.40 5/31/202287,600 shares $124.39 thousand -35.0%1.0%0.5 $1.42 5/15/2022134,800 shares $180.63 thousand +61.8%1.5%0.8 $1.34 4/30/202283,300 shares $147.44 thousand +1.0%1.0%0.5 $1.77 4/15/202282,500 shares $165.83 thousand +32.4%0.9%0.6 $2.01 3/31/202262,300 shares $138.31 thousand +3.2%0.7%0.4 $2.22 3/15/202260,400 shares $121.40 thousand -4.9%0.7%0.3 $2.01 2/28/202263,500 shares $137.80 thousand +15.9%0.7%0.1 $2.17 2/15/202254,800 shares $126.59 thousand -22.6%0.6%0.1 $2.31 1/31/202270,800 shares $150.80 thousand +17.8%0.8%0.1 $2.13 1/15/202260,100 shares $172.49 thousand -70.4%0.7%0.1 $2.87 12/31/2021203,000 shares $696.29 thousand -30.7%N/A0.2 $3.43 12/15/2021293,000 shares $1.13 million +222.0%3.3%0.3 $3.85 11/30/202191,000 shares $425.88 thousand -60.5%1.0%0.1 $4.68 11/15/2021230,100 shares $991.73 thousand -3.6%2.6%0.2 $4.31Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why (Ad)Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.Click here for the full story. 10/29/2021238,800 shares $998.18 thousand +8.2%2.7%0.1 $4.18 10/15/2021220,700 shares $988.74 thousand -25.2%2.5%0 $4.48 9/30/2021294,900 shares $1.42 million -11.1%3.3%0.1 $4.80 9/15/2021331,600 shares $2.00 million +35.2%6.8%0.1 $6.02 8/31/2021245,200 shares $4.68 million +103.8%11.9%0 $19.10 8/13/2021120,300 shares $544.96 thousand No Change5.8%0 $4.53 VRPX Short Interest - Frequently Asked Questions What is Virpax Pharmaceuticals' current short interest? Short interest is the volume of Virpax Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 11,900 shares of VRPX short. 0.25% of Virpax Pharmaceuticals' shares are currently sold short. Learn More on Virpax Pharmaceuticals' current short interest. What is a good short interest percentage for Virpax Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.25% of Virpax Pharmaceuticals' floating shares are currently sold short. Is Virpax Pharmaceuticals' short interest increasing or decreasing? Virpax Pharmaceuticals saw a drop in short interest in the month of July. As of July 31st, there was short interest totaling 11,900 shares, a drop of 22.7% from the previous total of 15,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Virpax Pharmaceuticals' short interest compare to its competitors? 0.25% of Virpax Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Virpax Pharmaceuticals: Navidea Biopharmaceuticals, Inc. (0.00%), Syros Pharmaceuticals, Inc. (0.31%), Smart for Life, Inc. (0.01%), Scopus BioPharma Inc. (0.03%), Statera Biopharma, Inc. (0.15%), Evelo Biosciences, Inc. (0.04%), Comera Life Sciences Holdings, Inc. (0.02%), Genocea Biosciences, Inc. (0.33%), Aridis Pharmaceuticals, Inc. (0.05%), Ampio Pharmaceuticals, Inc. (0.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Virpax Pharmaceuticals stock? Short selling VRPX is an investing strategy that aims to generate trading profit from Virpax Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Virpax Pharmaceuticals? A short squeeze for Virpax Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VRPX, which in turn drives the price of the stock up even further. How often is Virpax Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VRPX, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies NAVB Short Squeeze SYRS Short Squeeze SMFL Short Squeeze SCPS Short Squeeze STAB Short Squeeze EVLO Short Squeeze CMRA Short Squeeze GNCAQ Short Squeeze ARDS Short Squeeze AMPE Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VRPX) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersNew Banking Law #1582 Could Unlock $21 Trillion for AmericansDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virpax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Virpax Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VRPX Stock Alerts